Thromboembolism. A complication of weekly chemotherapy in the treatment of non‐Hodgkin's lymphoma

33Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a retrospective survey of 85 patients who received chemotherapy as treatment for non‐Hodgkin's lymphomas, the authors found that clinically apparent thromboembolic disorders occurred in four of 11 patients receiving weekly chemotherapy, and in none of 74 patients who were treated on less intensive schedules, suggesting that intensive weekly chemotherapy is thrombogenic. The possible mechanisms of this effect are discussed. Copyright © 1990 American Cancer Society

Cite

CITATION STYLE

APA

Clarke, C. S., Otridge, B. W., & Carney, D. N. (1990). Thromboembolism. A complication of weekly chemotherapy in the treatment of non‐Hodgkin’s lymphoma. Cancer, 66(9), 2027–2030. https://doi.org/10.1002/1097-0142(19901101)66:9<2027::AID-CNCR2820660930>3.0.CO;2-U

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free